Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
Article in Neuropathology and Applied Neurobiology (June 2021)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
Article in Scientific Reports (March 2018)
The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy
Article in Expert Opinion on Orphan Drugs (February 2018)